133 related articles for article (PubMed ID: 1375012)
1. The Sweet syndrome during therapy with granulocyte colony-stimulating factor.
Park JW; Mehrotra B; Barnett BO; Baron AD; Venook AP
Ann Intern Med; 1992 Jun; 116(12 Pt 1):996-8. PubMed ID: 1375012
[No Abstract] [Full Text] [Related]
2. Sweet syndrome associated with granulocyte colony-stimulating factor.
Bidyasar S; Montoya M; Suleman K; Markowitz AB
J Clin Oncol; 2008 Sep; 26(26):4355-6. PubMed ID: 18779624
[No Abstract] [Full Text] [Related]
3. Granulocyte colony-stimulating factor-induced Sweet syndrome in a healthy donor.
Oiso N; Watanabe K; Kawada A
Br J Haematol; 2006 Oct; 135(2):148. PubMed ID: 16856884
[No Abstract] [Full Text] [Related]
4. Images in haematology. Sweet's syndrome after granulocyte colony-stimulating factor administration for refractory myelodysplastic syndrome.
Matsumura T; Kami M
Br J Haematol; 2001 Apr; 113(1):1. PubMed ID: 11328271
[No Abstract] [Full Text] [Related]
5. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
6. [Neutrophilic dermatosis due to granulocyte-colony stimulating factor].
Izquierdo Herce N; Fernández López E; Roncero Riesco M; Zafra Cobo I
Med Clin (Barc); 2008 Jun; 131(2):80. PubMed ID: 18588837
[No Abstract] [Full Text] [Related]
7. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
Shi YK; Zhou JC; Feng FY
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
[TBL] [Abstract][Full Text] [Related]
8. Can granulocyte-colony stimulating factor worsen anemia?
Dang C; Hudis C
J Clin Oncol; 2006 Jul; 24(19):2985-6. PubMed ID: 16769981
[No Abstract] [Full Text] [Related]
9. Lymphoedema-area-restricted Sweet syndrome during G-CSF treatment.
Petit T; Frances C; Marinho E; Herson S; Chosidow O
Lancet; 1996 Mar; 347(9002):690. PubMed ID: 8596402
[No Abstract] [Full Text] [Related]
10. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
Macquart-Moulin G; Viens P; Palangié T; Bouscary ML; Delozier T; Roché H; Janvier M; Fabbro M; Moatti JP
J Clin Oncol; 2000 Feb; 18(4):754-64. PubMed ID: 10673516
[TBL] [Abstract][Full Text] [Related]
11. The Sweet syndrome or G-CSF reaction?
Karp DL
Ann Intern Med; 1992 Nov; 117(10):875-6. PubMed ID: 1384410
[No Abstract] [Full Text] [Related]
12. Cutaneous manifestations of granulocyte colony-stimulating factor.
White JM; Mufti GJ; Salisbury JR; du Vivier AW
Clin Exp Dermatol; 2006 Mar; 31(2):206-7. PubMed ID: 16487091
[TBL] [Abstract][Full Text] [Related]
13. Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.
de Wit R; Verweij J; Bontenbal M; Kruit WH; Seynaeve C; Schmitz PI; Stoter G
J Natl Cancer Inst; 1996 Oct; 88(19):1393-8. PubMed ID: 8827017
[TBL] [Abstract][Full Text] [Related]
14. Pegfilgrastim-induced Sweet's syndrome: a case report.
Machan M; Matthys B; Fraga GR
Int J Dermatol; 2014 Oct; 53(10):1275-7. PubMed ID: 23330634
[No Abstract] [Full Text] [Related]
15. [Anatomoclinical conference: breast cancer, hyperleukocytosis and respiratory failure].
Lemaitre F; Dagnelie J; Brohee D; Scagnol I; Sculier JP
Rev Med Brux; 1997 Apr; 18(2):75-8. PubMed ID: 9221466
[No Abstract] [Full Text] [Related]
16. Bullous Sweet's syndrome after granulocyte colony-stimulating factor therapy in a child with congenital neutropenia.
Akilov OE; Desai N; Jaffe R; Gehris RP
Pediatr Dermatol; 2014; 31(2):e61-2. PubMed ID: 24387761
[TBL] [Abstract][Full Text] [Related]
17. Lineage-specific hematopoietic growth factors.
Ferretti G; Papaldo P; Cognetti F
N Engl J Med; 2006 Aug; 355(5):526; author reply 527. PubMed ID: 16885561
[No Abstract] [Full Text] [Related]
18. Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type Ib.
Garty BZ; Levy I; Nitzan M; Barak Y
Pediatrics; 1996 Mar; 97(3):401-3. PubMed ID: 8604280
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation of palmoplantar pustulosis by granulocyte colony-stimulating factor.
Kurokawa I; Umehara M; Iwai T; Hamanishi S
Int J Dermatol; 2005 Jun; 44(6):529-30. PubMed ID: 15941453
[No Abstract] [Full Text] [Related]
20. A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer.
Iaffaioli RV; Tortoriello A; Facchini G; Santangelo M; De Sena G; Gesue G; Bucci L; Scaramellino G; Anastasio E; Finizio A
Br J Cancer; 1995 Nov; 72(5):1256-8. PubMed ID: 7577478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
